Donald A. Kennerly

2.1k total citations · 1 hit paper
35 papers, 1.7k citations indexed

About

Donald A. Kennerly is a scholar working on Molecular Biology, Biochemistry and Physiology. According to data from OpenAlex, Donald A. Kennerly has authored 35 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Biochemistry and 8 papers in Physiology. Recurrent topics in Donald A. Kennerly's work include Patient Safety and Medication Errors (7 papers), Lipid metabolism and biosynthesis (7 papers) and Mast cells and histamine (6 papers). Donald A. Kennerly is often cited by papers focused on Patient Safety and Medication Errors (7 papers), Lipid metabolism and biosynthesis (7 papers) and Mast cells and histamine (6 papers). Donald A. Kennerly collaborates with scholars based in United States, Israel and United Kingdom. Donald A. Kennerly's co-authors include N Stanford, Randy L. Bell, Philip W. Majerus, Charles W. Parker, Timothy J. Sullivan, Rebecca S. Gruchalla, Timothy J. Sullivan, C W Parker, Susan Roberts and David Nicewander and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Donald A. Kennerly

35 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diglyceride lipase: a pathway for arachidonate release from human platelets.

1979 561 citations Randy L. Bell, Donald A. Kennerly et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Donald A. Kennerly

Since Specialization

Citations

This map shows the geographic impact of Donald A. Kennerly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald A. Kennerly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald A. Kennerly more than expected).

Fields of papers citing papers by Donald A. Kennerly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald A. Kennerly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald A. Kennerly. The network helps show where Donald A. Kennerly may publish in the future.

Co-authorship network of co-authors of Donald A. Kennerly

This figure shows the co-authorship network connecting the top 25 collaborators of Donald A. Kennerly. A scholar is included among the top collaborators of Donald A. Kennerly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald A. Kennerly. Donald A. Kennerly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and Testing of Baylor Scott & White Health's “Attitudes and Practices of Patient Safety Survey” 2016 ·Baylor University Medical Center Proceedings ·Sunni A. Barnes, (unknown), (unknown), Kristen M. Tecson, (unknown), Donald A. Kennerly	2
2	Development of a Tool to Measure User Experience Following Electronic Health Record Implementation 2014 ·JONA The Journal of Nursing Administration ·Yan Xiao, (unknown), Lindsey M. Philpot, Sunni A. Barnes, (unknown), Donald A. Kennerly	11
3	Description and Evaluation of Adaptations to the Global Trigger Tool to Enhance Value to Adverse Event Reduction Efforts 2013 ·Journal of Patient Safety ·Donald A. Kennerly, (unknown), Rustam Kudyakov, Briget da Graca, David Nicewander, (unknown)	27
4	Safety Issues Related to the Electronic Medical Record (EMR): Synthesis of the Literature from the Last Decade, 2000-2009 2011 ·Journal of Healthcare Management ·Linda Harrington, Donald A. Kennerly, Constance Johnson	62
5	Large-scale deployment of the Global Trigger Tool across a large hospital system: refinements for the characterisation of adverse events to support patient safety learning opportunities 2011 ·BMJ Quality & Safety ·Vicki S. Good, Miguel Ángel Mariscal Saldaña, Richard E. Gilder, David Nicewander, Donald A. Kennerly	49
6	Development and Dissemination of Minimum Standards of Care for Asthma 2000 ·Journal for Healthcare Quality ·Donald A. Kennerly, Mark Millard, (unknown)	5
7	Impact of the National Asthma Guidelines on Internal Medicine Primary Care and Specialty Practice 2000 ·Baylor University Medical Center Proceedings ·(unknown), Mark Millard, Donald A. Kennerly, (unknown)	6
8	Asthma Disease Management: Friend or Foe? 1999 ·Allergy and Asthma Proceedings ·Donald A. Kennerly	3
9	Comparison of diglyceride production from choline-containing phosphoglycerides in human neutrophils stimulated with N-formylmethionyl-leucylphenylalanine, ionophore A23187 or phorbol 12-myristate 13-acetate 1992 ·Biochemical Journal ·Marie Chabot, Linda C. McPhail, Robert L. Wykle, Donald A. Kennerly, Charles E. McCall	25
10	Assessment of receptor-dependent activation of phosphatidylcholine hydrolysis by both phospholipase D and phospholipase C. 1991 ·PubMed ·(unknown), Donald A. Kennerly	19
11	Phosphatidylcholine is a quantitatively more important source of increased 1,2-diacylglycerol than is phosphatidylinositol in mast cells. 1990 ·The Journal of Immunology ·Donald A. Kennerly	34
12	An indirect pathway of receptor-mediated 1,2-diacylglycerol formation in mast cells. I. IgE receptor-mediated activation of phospholipase D. 1990 ·The Journal of Immunology ·Rebecca S. Gruchalla, (unknown), Donald A. Kennerly	95
13	Isolation and enzymic assay of choline and phosphocholine present in cell extracts with picomole sensitivity 1990 ·Biochemical Journal ·John Murray, (unknown), (unknown), Donald A. Kennerly	25
14	Two-dimensional thin-layer chromatographic separation of phospholipid molecular species using plates with both reversed-phase and argentation zones 1988 ·Journal of Chromatography A ·Donald A. Kennerly	6
15	Molecular species analysis of lysophospholipids using high-performance liquid chromatography and argentation thin-layer chromatography 1987 ·Journal of Chromatography A ·Donald A. Kennerly	8
16	Preparation and characterization of mast cell cytoplasts 1987 ·Journal of Immunological Methods ·Donald A. Kennerly	4
17	Diacylglycerol metabolism in mast cells: a potential role in membrane fusion and arachidonic acid release. 1979 ·The Journal of Experimental Medicine ·Donald A. Kennerly, Timothy J. Sullivan, (unknown), C W Parker	101
18	Diglyceride lipase: a pathway for arachidonate release from human platelets. breakdown → 1979 ·Proceedings of the National Academy of Sciences ·Randy L. Bell, Donald A. Kennerly, N Stanford, Philip W. Majerus	561
19	Use of diacylglycerol kinase to quantitate picomole levels of 1,2-diacylglycerol 1979 ·Analytical Biochemistry ·Donald A. Kennerly, Charles W. Parker, Timothy J. Sullivan	60
20	Activation of Phospholipid Metabolism During Mediator Release from Stimulated Rat Mast Cells 1979 ·The Journal of Immunology ·Donald A. Kennerly, Timothy J. Sullivan, Charles W. Parker	130

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact